Ei.Ventures

Our mission is bold… empower people worldwide to good mental health. To this end, our botanical psychedelic therapeutics and medicinal mushroom nutraceutical solutions are designed to radically shift mental wellness treatment protocols.

EI.Ventures is focused on developing botanical API for the psychedelic supply chain, novel psychedelic compounds for various indications, uninque delivery mechanisms and treatment protocols, and medicinal mushroom nutraceuticals for improving well-being and health. 

Ultimately, we intend to create a revolution when it comes to mental health and wellness. Our aim is to open the pathway to the billion + people worldwide who need to receive these life-changing treatments and natural solutions.

Developing the 'Psychedelic Farmers Market', the first link in the psyechedlic therapeutics supply chain
Control IP for three botanical novel psychedelic formulations. Psilly™️, MY-D™️, MY-MDMA™️
CRO and lab partnerships created in Canada for the development of Psychedelic API and novel compounds like Psilly™️
Developing mental wellness and health app partnerships for launch in 2021
Launching our MANA™️ medicinal mushroom nutraceuticals in Q1 of 2021 into a $15 billion a year market

The Company’s management will have broad discretion in the application of the net proceeds of this Offering and investors will have to rely upon their judgment. At present, At present, we intend to use the net proceeds for:

1. conducting pre-clinical, clinical development for our drug candidates, and related research programs;
2. intellectual property development or acquisition; and
3. general corporate purposes. The failure by the Company’s management to apply these funds effectively could have a material adverse effect on the Company and the value of the Securities.